These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression and functional analyses of breast cancer resistance protein in lung cancer. Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956 [TBL] [Abstract][Full Text] [Related]
5. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Ross DD; Karp JE; Chen TT; Doyle LA Blood; 2000 Jul; 96(1):365-8. PubMed ID: 10891476 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944 [TBL] [Abstract][Full Text] [Related]
7. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183 [TBL] [Abstract][Full Text] [Related]
8. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples. Illmer T; Schaich M; Oelschlägel U; Nowak R; Renner U; Ziegs B; Subat S; Neubauer A; Ehninger G Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187 [TBL] [Abstract][Full Text] [Related]
9. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536 [TBL] [Abstract][Full Text] [Related]
10. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622 [TBL] [Abstract][Full Text] [Related]
15. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Ho MM; Hogge DE; Ling V Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061 [TBL] [Abstract][Full Text] [Related]
16. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase. Ji N; Yuan J; Liu J; Tian S Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. Sargent JM; Williamson CJ; Maliepaard M; Elgie AW; Scheper RJ; Taylor CG Br J Haematol; 2001 Nov; 115(2):257-62. PubMed ID: 11703319 [TBL] [Abstract][Full Text] [Related]
18. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996 [TBL] [Abstract][Full Text] [Related]
19. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137 [TBL] [Abstract][Full Text] [Related]
20. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias. Beck J; Niethammer D; Gekeler V Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]